Commit To Purchase Cytokinetics At $4, Earn 14.1% Annualized Using Options
July 07, 2015 at 11:32 AM EDT
Investors eyeing a purchase of Cytokinetics Inc (CYTK) shares, but tentative about paying the going market price of $6.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2016 put at the $4 strike, which has a bid at the time of this writing of 35 cents..